Table 2. Anti-H5N1 activities of benzothiophene-based benzenesulfonamide derivatives 12a–s in MDCK cells a .
| |||||||
| Entry | Cmpd | Core structure | R | EC50 b (μM) AMD-sensitive H5N1 | EC50 c (μM) AMD-resistant H5N1 | CC50 d (μM) | SI e |
| 1 | 12a |
|
4-NO2 | 1.38 ± 0.29 | NA | >191.45 | >138.7 |
| 2 | 12b | 4-CN | 20.28 ± 8.34 | NA | 122.41 ± 32.59 | 6.0 | |
| 3 | 12c | 4-F | 3.42 ± 0.81 | NA | 98.64 ± 29.25 | 28.8 | |
| 4 | 12d | 4-Cl | 1.98 ± 0.68 | NA | 69.56 ± 15.39 | 35.1 | |
| 5 | 12e | 4-Br | 7.22 ± 1.60 | NA | 87.11 ± 21.71 | 12.1 | |
| 6 | 12f | 4-CF3 | 38.56 ± 14.73 | NA | 94.78 ± 14.27 | 2.5 | |
| 7 | 12g | 4-Me | 10.49 ± 3.78 | NA | >210.13 | >20.0 | |
| 8 | 12h | 2-F | NA f | NA | — g | — h | |
| 9 | 12i | 3-F | NA | NA | — | — | |
| 10 | 12j | 4-COCH3 | 12.04 ± 3.85 | NA | >193.09 | >16.0 | |
| 11 | 12k |
|
4-NO2 | 49.97 ± 14.87 | NA | >191.45 | >3.8 |
| 12 | 12l | 4-CN | NA | NA | — | — | |
| 13 | 12m | 4-F | NA | NA | — | — | |
| 14 | 12n | 4-Cl | NA | NA | — | — | |
| 15 | 12o | 4-Br | 40.70 ± 12.11 | NA | >174.47 | >4.3 | |
| 16 | 12p | 4-CF3 | 44.83 ± 16.51 | NA | >179.60 | >4.0 | |
| 17 | 12q | 4-Me | 41.96 ± 13.74 | NA | >210.13 | >5.0 | |
| 18 | 12r | 2-F | NA | NA | — | — | |
| 19 | 12s | 3-F | NA | NA | — | — | |
| 20 | AMD | 0.43 ± 0.13 | NA | >100.00 | >235.3 | ||
| 21 | Oseltamivir phosphate | 0.39 ± 0.10 | 0.34 ± 0.02 | >163.26 | >418.6 | ||
aAll data were obtained from at least three independent experiments.
bEC50, concentration that effectively inhibited amantadine-sensitive H5N1 virus plaque formation by 50%.
cEC50, concentration that effectively inhibited amantadine-resistant H5N1 virus plaque formation by 50%.
dCC50, concentration that inhibited cell growth by 50% compared with control cultures.
eSelectivity index (SI) was determined for the effective compounds by dividing CC50 by EC50 (amantadine-sensitive H5N1 virus).
fNA: no activity (EC50 > 100 μM).
g—: no detection.
h—: no selectivity index.